Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections
Albert D.M.E. Osterhaus
Albert D.M.E. OsterhausFrom the Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven (Osterhaus, Siebelink, Rimmelzwaan, Bosch), and the Division of Immunology, The Netherlands Cancer Institute, Amsterdam, (Weijer) The Netherlands.
K. WeijerFrom the Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven (Osterhaus, Siebelink, Rimmelzwaan, Bosch), and the Division of Immunology, The Netherlands Cancer Institute, Amsterdam, (Weijer) The Netherlands.
K.H.J. SiebelinkFrom the Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven (Osterhaus, Siebelink, Rimmelzwaan, Bosch), and the Division of Immunology, The Netherlands Cancer Institute, Amsterdam, (Weijer) The Netherlands.
G.F. RimmelzwaanFrom the Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven (Osterhaus, Siebelink, Rimmelzwaan, Bosch), and the Division of Immunology, The Netherlands Cancer Institute, Amsterdam, (Weijer) The Netherlands.
M.L. BoschFrom the Laboratory of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven (Osterhaus, Siebelink, Rimmelzwaan, Bosch), and the Division of Immunology, The Netherlands Cancer Institute, Amsterdam, (Weijer) The Netherlands.